ArticleFrontiers in plant science2025
Robust plant disease segmentation in complex field environments: an in-depth analysis and validation with STAR-Net.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Plant disease segmentation in real-world agricultural environments poses significant technical challenges, including complex backgrounds, diverse lesion morphologies, and extreme class imbalance. Methods: In this paper, we propose an integrated solution, STAR-Net, which combines a novel network architecture with a dynamic training strategy. The architecture features an innovative Heterogeneous Branch Attention Aggregation (HBAA) module to robustly represent multi-scale and multi-morphology features. The training strategy employs a Dynamic Phase-Weighted Loss (DPW-Loss) to navigate the complexities of imbalanced data. Results: Our method achieves a state-of-the-art average mIoU of 93.36% on the NLB dataset. This result demonstrates its superior ability to precisely segment diseases with specific elongated morphologies. Furthermore, the model obtains a competitive average mIoU of 41.13% on the highly challenging PlantSeg dataset. This result validates its robustness in complex 'in-the-wild' scenarios. Discussion: Our work presents a powerful, well validated, and synergistic solution for plant disease segmentation. It also paves the way for practical applications in precision agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.